Method and device for removal of cryoprotectant from cryopreserved biological cells and tissues

• US 6,869,758 B1
• Filed: 07/26/2002
• Issued: 03/22/2005
• Est. Priority Date: 07/26/2000
• Status: Expired due to Fees

• Current Assignee: University Of Kentucky Research Foundation (University of Kentucky)
• Original Assignee: University Of Kentucky Research Foundation (University of Kentucky)
• Inventors: Gao, Dayong, Cui, XiangDong
• Primary Examiner(s): Saucier, Sandra E.
• Application Number:
  US10/206,539
• Time in Patent Office: 970 Days
• Field of Search: 435/1.1, 435/1.2, 435/1.3, 435/2, 435/325
• US Class Current: 435/1.1
• CPC Class Codes: A01N 1/0221 Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
• CPC Class Codes: A01N 1/0278 Physical preservation processes
• CPC Class Codes: B01D 63/02 Hollow fibre modules
• CPC Class Codes: B01D 63/034 Lumen open in more than two directions

Abstract

Novel methods and devices for removing cryoprotectant from cryoprotectant-containing liquids, and from cells residing therein, are disclosed. In one aspect, the method comprises passing the cryoprotectant-containing liquid through at least one semipermeable hollow fiber membrane contained in a hollow module in a first direction, while passing a liquid which is substantially free of cryoprotectant through the hollow module in a second direction to remove cryoprotectant across a diffusion gradient. In another aspect, a device is described for removing cryoprotectant from a liquid, comprising a hollow module with at least one semipermeable hollow fiber membrane therein for accomplishing such counter-current diffusion removal of cryprotectant. A software program is also provided for predicting optimal flow rates through the device of the invention, thereby allowing optimal cryoprotectant removal regardless of the cryoprotectant used or the material from which the semipermeable hollow fiber membrane is fabricated.

Claims

1. A method for removing a cryoprotectant from an interior of a cell immersed in a cryoprotectant-containing liquid, comprising the steps of:

passing the cryoprotectant-containing liquid through at least one semipermeable hollow fiber membrane contained in a hollow module in a first direction to contact said hollow fiber membrane on at least one interior surface;

passing a liquid which is substantially free of cryoprotectant through said hollow module in a second direction opposite to said first direction so that said cryoprotectant-free liquid contacts said semipermeable hollow fiber membrane on at least one exterior surface; and

transferring said cryoprotectant from said cryoprotectant-containing liquid to said cryoprotectant-free liquid across a diffusion gradient between said interior surface and said exterior surface of said semipermeable hollow fiber membrane.

2. The method of claim 1, wherein said cell is contained in said cryoprotectant-containing liquid in a suspension.

3. The method of claim 1, wherein said cell is a tissue block immersed in said cryoprotectant-containing liquid.

4. The method of claim 1, wherein said cell is seeded in a porous growth matrix immersed in said cryoprotectant-containing liquid.

5. The method of claim 1, wherein said cell is grown in a monolayer on a surface matrix immersed in said cryoprotectant-containing liquid.

6. The method of claim 2, wherein said semipermeable hollow fiber membrane has a porosity of from about 50% to about 80%.

7. The method of claim 2, wherein said semipermeable hollow fiber membrane has a porosity of about 70%.

8. The method of claim 1, wherein said first flow rate is sufficient to allow transfer of cryoprotectant contained in said cryoprotectant-containing liquid from said interior surface of said semipermeable hollow fiber membrane to said exterior surface of said semipermeable hollow fiber membrane.

9. The method of claim 1, wherein said second flow rate is sufficient to substantially prevent retention of cryoprotectant on said exterior surface of said semipermeable hollow fiber membrane.

17. The method of claim 1, wherein said first flow rate is sufficient to allow transfer of cryoprotectant contained in said cryoprotectant-containing liquid from said interior surface of said semipermeable hollow fiber membrane to said exterior surface of said semipermeable hollow fiber membrane.

18. The method of claim 1, wherein said second flow rate is sufficient to substantially prevent retention of cryoprotectant on said exterior surface of said semipermeable hollow fiber membrane.

10. A method for removing a cryoprotectant from an interior of a cell immersed in a cryoprotectant-containing liquid, comprising the steps of:

determining a membrane transfer potential of a semipermeable hollow fiber membrane for said cryoprotectant;

calculating a first flow rate based on said membrane transfer potential for passing the cryoprotectant-containing liquid through said semipermeable hollow fiber membrane to remove said cryoprotectant from said cryoprotectant-containing liquid;

calculating a second flow rate based on said membrane transfer potential for passing a cryoprotectant-free liquid through said hollow module;

passing the cryoprotectant-containing liquid through at least one said semipermeable hollow fiber membrane contained within the hollow module at said first flow rate in a first direction to contact said hollow fiber membrane on at least one interior surface;

passing the cryoprotectant-free liquid at said second flow rate through the hollow module in a second direction opposite to said first direction so that said cryoprotectant-free liquid contacts said semipermeable hollow fiber on at least one exterior surface; and

transferring said cryoprotectant from said cryoprotectant-containing liquid to said cryoprotectant-free liquid across a diffusion gradient created between said interior surface and said exterior surface of said semipermeable hollow fiber.

11. The method of claim 10, wherein said cell is contained in said cryoprotectant-containing liquid in suspension.

12. The method of claim 10, wherein said cell is contained in a tissue block immersed in said cryoprotectant-containing liquid.

13. The method of claim 10, wherein said cell is contained in a porous growth matrix immersed in said cryoprotectant-containing liquid.

14. The method of claim 10, wherein said cell is grown in monolayer culture on a solid matrix prior to immersion in said cryoprotectant-containing liquid.

15. The method of claim 10, wherein said porous hollow fiber membrane has a porosity of from about 50% to about 80%.

16. The method of claim 10, wherein said porous hollow fiber membrane has a porosity of about 70%.